Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT00628355 Terminated - Pelvic Pain Clinical Trials

Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment

Start date: February 2008
Phase: Phase 4
Study type: Interventional

Our hypothesis is that with comparison of effectiveness of two most common techniques of treatment for myofascial pain syndrome (injection of local anesthesia and ischemic compression) we could choice the most adequate to treat this disease. This way we could decrease the expenses with medicines, examinations, consultations and the time that women remains without a diagnosis and treatment.

NCT ID: NCT00607256 Terminated - Fibromyalgia Clinical Trials

Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

Start date: October 20, 2007
Phase: Phase 3
Study type: Interventional

To evaluate the lon-term safety and tolerability of [S,S]-reboxetine in patients with fibromyalgia

NCT ID: NCT00450905 Terminated - Pain Clinical Trials

Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study is being performed to determine the safety and efficacy of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain associated with Fibromyalgia.

NCT ID: NCT00445705 Terminated - Fibromyalgia Clinical Trials

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

Start date: March 2007
Phase: Phase 2
Study type: Interventional

This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with fibromyalgia syndrome. The study is being conducted in 2 parts. Part A enrolled 211 pts dosed with either 3, 20, 60 mg BID AGN 203818 or placebo over 4 week treatment duration. Part B will enroll 440 pts and dose with either 20, 100, 160 mg BID AGN 203818 or placebo over 12 week treatment duration.

NCT ID: NCT00301431 Terminated - Fibromyalgia Clinical Trials

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Start date: August 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.